Key facts
- This page summarizes Gary A. Lyons's Form 4 filing for RIGEL PHARMACEUTICALS INC (RIGL).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Jul 2023, 18:45.
Gary A. Lyons - 26 May 2023 Form 4 Insider Report for RIGEL PHARMACEUTICALS INC (RIGL)
- Reporting relationship
- Director
- Issuer ticker
- RIGL
- Reported as of
- 26 May 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 12 Jul 2023, 18:45:31 UTC
- Prior SEC filing
- 19 May 2023
- Next SEC filing
- 06 Sep 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Raymond Furey (Attorney-in-Fact)
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Gary A. Lyons filed Form 4 for RIGEL PHARMACEUTICALS INC (RIGL) on 12 Jul 2023.
Change
- Previous filing in this sequence was filed on 19 May 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RIGL
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +25,000
- Change %
- +50%
- Price
- $0.000000
- Shares after
- 75,000
- Date
- 26 May 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RIGL
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +30,000
- Change %
- Price
- $0.000000
- Shares after
- 30,000
- Date
- 26 May 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 30,000
- Exercise price
- $1.32
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors.
Footnote F2
The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors.
SEC remarks
Exhibit List: Exhibit 24 - Power of Attorney